Last 12 months
Inside the activity.
0 purchase rows · 54 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 2, 2026 22:50 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 11,340 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-26-002878 · doc4.xml · derivative · entry 5 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,680 Underlying: Common Stock · 11,340 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2026 Filed Mar 2, 2026 22:50 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 11,340 | $85.93 | $974,430.32 |
DisclosureSEC source: 0001225208-26-002878 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,266.2532 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $85.665 to $86.380. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2026 Filed Mar 2, 2026 22:50 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 11,340 | $59.26 | $671,970.98 |
DisclosureSEC source: 0001225208-26-002878 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,606.2532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 00:33 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 24,000 | $83.84 | $2,012,076.00 |
DisclosureSEC source: 0001225208-26-002711 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,266.2532 F1 · price: This transaction was executed in multiple trades at prices ranging from $83.66 to $83.96. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Total reflects the correction of 13,396 shares held indirectly by the Reporting Person's trust, which were previously reported as directly held. Read SEC document |
| February 22, 2026 Filed Feb 23, 2026 22:08 UTC |
Lippis Daniel J.CVP, TAVR
|
Tax withholdingCommon Stock | 432 | $79.78 | $34,464.96 |
DisclosureSEC source: 0001225208-26-002409 · doc4.xml · nonDerivative · entry 1 Lippis Daniel J. · CIK 0002004380 · CVP, TAVR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,933.9103 Read SEC document |
| February 22, 2026 Filed Feb 23, 2026 22:08 UTC |
Dahl Andrew M.SVP, Corporate Controller
|
Tax withholdingCommon Stock | 176 | $79.78 | $14,041.28 |
DisclosureSEC source: 0001225208-26-002408 · doc4.xml · nonDerivative · entry 1 Dahl Andrew M. · CIK 0002022347 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,089.4805 Read SEC document |
| February 17, 2026 Filed Feb 17, 2026 22:16 UTC |
Lippis Daniel J.CVP, TAVR
|
Tax withholdingCommon Stock | 198 | $75.87 | $15,022.26 |
DisclosureSEC source: 0001225208-26-001986 · doc4.xml · nonDerivative · entry 3 Lippis Daniel J. · CIK 0002004380 · CVP, TAVR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,365.9103 Read SEC document |
| February 16, 2026 Filed Feb 17, 2026 22:16 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 199 | $75.87 | $15,098.13 |
DisclosureSEC source: 0001225208-26-001987 · doc4.xml · nonDerivative · entry 1 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,699 Read SEC document |
| February 16, 2026 Filed Feb 17, 2026 22:16 UTC |
Lippis Daniel J.CVP, TAVR
|
Tax withholdingCommon Stock | 258 | $75.87 | $19,574.46 |
DisclosureSEC source: 0001225208-26-001986 · doc4.xml · nonDerivative · entry 2 Lippis Daniel J. · CIK 0002004380 · CVP, TAVR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,563.9103 Read SEC document |
| February 13, 2026 Filed Feb 13, 2026 22:37 UTC |
Zovighian Bernard JDirector · CEO
|
GiftCommon Stock | 2,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-001893 · doc4.xml · nonDerivative · entry 5 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 11,516.5511 Read SEC document |
| February 13, 2026 Filed Feb 13, 2026 22:37 UTC |
Zovighian Bernard JDirector · CEO
|
GiftCommon Stock | 2,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-001893 · doc4.xml · nonDerivative · entry 4 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,976 Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 22:37 UTC |
Zovighian Bernard JDirector · CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 25,350 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-26-001893 · doc4.xml · derivative · entry 7 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,350 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on May 8, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 22:37 UTC |
Zovighian Bernard JDirector · CEO
|
SaleCommon Stock | 19,898 | $76.61 | $1,524,451.44 |
DisclosureSEC source: 0001225208-26-001893 · doc4.xml · nonDerivative · entry 3 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,896 F2 · price: This transaction was executed in multiple trades at prices ranging from $76.080 to $77.075 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 22:37 UTC |
Zovighian Bernard JDirector · CEO
|
SaleCommon Stock | 2,532 | $77.13 | $195,289.87 |
DisclosureSEC source: 0001225208-26-001893 · doc4.xml · nonDerivative · entry 2 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,794 F1 · price: This transaction was executed in multiple trades at prices ranging from $77.080 to $77.225 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 12, 2026 Filed Feb 13, 2026 22:37 UTC |
Zovighian Bernard JDirector · CEO
|
Exercise / conversionCommon Stock | 25,350 | $59.26 | $1,502,157.35 |
DisclosureSEC source: 0001225208-26-001893 · doc4.xml · nonDerivative · entry 1 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 22:16 UTC |
Lippis Daniel J.CVP, TAVR
|
GrantCommon Stock | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-001986 · doc4.xml · nonDerivative · entry 1 Lippis Daniel J. · CIK 0002004380 · CVP, TAVR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,821.9103 F1 · shares: These restricted stock units were granted on February 12, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. Read SEC document |
| January 09, 2026 Filed Jan 9, 2026 22:41 UTC |
Lippis Daniel J.CVP, TAVR
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 1,019 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-26-000558 · doc4.xml · derivative · entry 3 Lippis Daniel J. · CIK 0002004380 · CVP, TAVR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,076 Underlying: Common Stock · 1,019 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2026 Filed Jan 9, 2026 22:41 UTC |
Lippis Daniel J.CVP, TAVR
|
SaleCommon Stock | 1,019 | $85.70 | $87,332.07 |
DisclosureSEC source: 0001225208-26-000558 · doc4.xml · nonDerivative · entry 2 Lippis Daniel J. · CIK 0002004380 · CVP, TAVR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,001.9103 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $85.45 to $85.95. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of theIssuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 09, 2026 Filed Jan 9, 2026 22:41 UTC |
Lippis Daniel J.CVP, TAVR
|
Exercise / conversionCommon Stock | 1,019 | $59.26 | $60,382.58 |
DisclosureSEC source: 0001225208-26-000558 · doc4.xml · nonDerivative · entry 1 Lippis Daniel J. · CIK 0002004380 · CVP, TAVR 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,020.9103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025. Read SEC document |
| January 06, 2026 Filed Jan 6, 2026 23:02 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 11,340 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-26-000378 · doc4.xml · derivative · entry 6 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,020 Underlying: Common Stock · 11,340 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2026 Filed Jan 6, 2026 23:02 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 8,708 | $85.98 | $748,707.74 |
DisclosureSEC source: 0001225208-26-000378 · doc4.xml · nonDerivative · entry 3 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,870.2532 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $85.40 to $86.10. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 06, 2026 Filed Jan 6, 2026 23:02 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 2,632 | $84.62 | $222,721.42 |
DisclosureSEC source: 0001225208-26-000378 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,578.2532 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $84.39 to $85.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 06, 2026 Filed Jan 6, 2026 23:02 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 11,340 | $59.26 | $671,970.98 |
DisclosureSEC source: 0001225208-26-000378 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,210.2532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025. Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 22:57 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
GiftCommon Stock | 7,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009935 · doc4.xml · nonDerivative · entry 3 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,870.2532 Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 22:57 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 5,900 | $83.74 | $494,066.00 |
DisclosureSEC source: 0001225208-25-009935 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,970.2532 Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 22:57 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 5,486.1175 | $83.79 | $459,681.79 |
DisclosureSEC source: 0001225208-25-009935 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,870.2532 Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 22:57 UTC |
Lippis Daniel J.CVP, JAPAC
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 1,019 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-25-009934 · doc4.xml · derivative · entry 3 Lippis Daniel J. · CIK 0002004380 · CVP, JAPAC 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,095 Underlying: Common Stock · 1,019 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 22:57 UTC |
Lippis Daniel J.CVP, JAPAC
|
SaleCommon Stock | 1,019 | $84.03 | $85,625.25 |
DisclosureSEC source: 0001225208-25-009934 · doc4.xml · nonDerivative · entry 2 Lippis Daniel J. · CIK 0002004380 · CVP, JAPAC 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,001.9103 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $83.58 to $84.46. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 22:57 UTC |
Lippis Daniel J.CVP, JAPAC
|
Exercise / conversionCommon Stock | 1,019 | $59.26 | $60,382.58 |
DisclosureSEC source: 0001225208-25-009934 · doc4.xml · nonDerivative · entry 1 Lippis Daniel J. · CIK 0002004380 · CVP, JAPAC 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,020.9103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 30, 2025. Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 22:57 UTC |
STONE HEISZ LESLIEDirector
|
SaleCommon Stock | 2,615 | $83.41 | $218,119.50 |
DisclosureSEC source: 0001225208-25-009933 · doc4.xml · nonDerivative · entry 1 STONE HEISZ LESLIE · CIK 0001235408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,948 Read SEC document |
| December 11, 2025 Filed Dec 11, 2025 22:58 UTC |
Chopra DaveenCVP, TMTT & Surgical
|
SaleCommon Stock | 2,000 | $84.38 | $168,750.20 |
DisclosureSEC source: 0001225208-25-009873 · doc4.xml · nonDerivative · entry 1 Chopra Daveen · CIK 0001740963 · CVP, TMTT & Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,201 Read SEC document |
| December 10, 2025 Filed Dec 10, 2025 23:58 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 11,340 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-25-009841 · doc4.xml · derivative · entry 5 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,360 Underlying: Common Stock · 11,340 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2025 Filed Dec 10, 2025 23:58 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 11,340 | $83.83 | $950,581.17 |
DisclosureSEC source: 0001225208-25-009841 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,356.3707 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $83.465 to $84.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 10, 2025 Filed Dec 10, 2025 23:58 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 11,340 | $59.26 | $671,970.98 |
DisclosureSEC source: 0001225208-25-009841 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,696.3707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025. Read SEC document |
| December 10, 2025 Filed Dec 10, 2025 23:58 UTC |
Zovighian Bernard JDirector · CEO
|
SaleCommon Stock | 3,863 | $83.45 | $322,367.35 |
DisclosureSEC source: 0001225208-25-009840 · doc4.xml · nonDerivative · entry 5 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 8,596.5511 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025. Read SEC document |
| December 09, 2025 Filed Dec 9, 2025 22:01 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,700 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-25-009797 · doc4.xml · derivative · entry 4 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,000 Underlying: Common Stock · 7,700 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2025 Filed Dec 9, 2025 22:01 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
SaleCommon Stock | 7,700 | $84.47 | $650,412.07 |
DisclosureSEC source: 0001225208-25-009797 · doc4.xml · nonDerivative · entry 2 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,898 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $84.09 to $85.07. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 09, 2025 Filed Dec 9, 2025 22:01 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 7,700 | $59.26 | $456,276.59 |
DisclosureSEC source: 0001225208-25-009797 · doc4.xml · nonDerivative · entry 1 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025. Read SEC document |
| December 09, 2025 Filed Dec 10, 2025 23:58 UTC |
Zovighian Bernard JDirector · CEO
|
GiftCommon Stock | 3,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009840 · doc4.xml · nonDerivative · entry 4 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 12,459.5511 Read SEC document |
| December 09, 2025 Filed Dec 10, 2025 23:58 UTC |
Zovighian Bernard JDirector · CEO
|
GiftCommon Stock | 3,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009840 · doc4.xml · nonDerivative · entry 3 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,976 Read SEC document |
| December 08, 2025 Filed Dec 8, 2025 22:50 UTC |
Markowitz WayneCVP, JAPAC
|
SaleCommon Stock | 583 | $86.01 | $50,143.83 |
DisclosureSEC source: 0001225208-25-009791 · doc4.xml · nonDerivative · entry 1 Markowitz Wayne · CIK 0001991414 · CVP, JAPAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,562.8708 Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 23:58 UTC |
Zovighian Bernard JDirector · CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 25,350 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-25-009840 · doc4.xml · derivative · entry 7 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,350 Underlying: Common Stock · 25,350 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on May 8, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 23:58 UTC |
Zovighian Bernard JDirector · CEO
|
SaleCommon Stock | 21,487 | $85.21 | $1,831,006.11 |
DisclosureSEC source: 0001225208-25-009840 · doc4.xml · nonDerivative · entry 2 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,839 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $84.63 to $85.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 23:58 UTC |
Zovighian Bernard JDirector · CEO
|
Exercise / conversionCommon Stock | 25,350 | $59.26 | $1,502,157.35 |
DisclosureSEC source: 0001225208-25-009840 · doc4.xml · nonDerivative · entry 1 Zovighian Bernard J · CIK 0001665141 · Director · CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 00:52 UTC |
Dahl Andrew M.SVP, Corporate Controller
|
GrantCommon Stock | 1,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-009137 · doc4.xml · nonDerivative · entry 1 Dahl Andrew M. · CIK 0002022347 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,183.074 F1 · shares: These restricted stock units were granted on November 13, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. Read SEC document |
| November 10, 2025 Filed Nov 10, 2025 23:07 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 13,000 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-25-009067 · doc4.xml · derivative · entry 5 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,700 Underlying: Common Stock · 13,000 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2025 Filed Nov 10, 2025 23:07 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
SaleCommon Stock | 10,026 | $83.02 | $832,359.52 |
DisclosureSEC source: 0001225208-25-009067 · doc4.xml · nonDerivative · entry 3 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,898 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $82.270 to $83.260. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2025 Filed Nov 10, 2025 23:07 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
SaleCommon Stock | 2,974 | $83.30 | $247,733.90 |
DisclosureSEC source: 0001225208-25-009067 · doc4.xml · nonDerivative · entry 2 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,924 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $83.270 to $83.415. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2025 Filed Nov 10, 2025 23:07 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 13,000 | $59.26 | $770,337.10 |
DisclosureSEC source: 0001225208-25-009067 · doc4.xml · nonDerivative · entry 1 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025. Read SEC document |
| November 10, 2025 Filed Nov 10, 2025 23:06 UTC |
Lippis Daniel J.CVP, JAPAC
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 1,020 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-25-009066 · doc4.xml · derivative · entry 3 Lippis Daniel J. · CIK 0002004380 · CVP, JAPAC 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,114 Underlying: Common Stock · 1,020 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.